Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2006 | 1 |
2007 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer.
Endocr Relat Cancer. 2005 Dec;12(4):721-47. doi: 10.1677/erc.1.00857.
Endocr Relat Cancer. 2005.
PMID: 16322319
Review.
First-line chemotherapy for HER-2 negative metastatic breast cancer patients who received anthracyclines as adjuvant treatment.
Morabito A, Piccirillo MC, Monaco K, Pacilio C, Nuzzo F, Chiodini P, Gallo C, de Matteis A, Perrone F; NCI Naples Breast Cancer Group.
Morabito A, et al.
Oncologist. 2007 Nov;12(11):1288-98. doi: 10.1634/theoncologist.12-11-1288.
Oncologist. 2007.
PMID: 18055848
Free article.
Review.
Item in Clipboard
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial.
Pacilio C, Morabito A, Nuzzo F, Gravina A, Labonia V, Landi G, Rossi E, De Maio E, Di Maio M, D'Aiuto G, Botti G, Normanno N, Chiodini P, Gallo C, Perrone F, de Matteis A; NCI-Naples Breast Cancer Group.
Pacilio C, et al.
Br J Cancer. 2006 May 8;94(9):1233-6. doi: 10.1038/sj.bjc.6603096.
Br J Cancer. 2006.
PMID: 16622454
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite